GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alk-Abello AS (OCSE:ALK B) » Definitions » Beneish M-Score

Alk-Abello AS (OCSE:ALK B) Beneish M-Score : -2.71 (As of Sep. 24, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Alk-Abello AS Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.71 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Alk-Abello AS's Beneish M-Score or its related term are showing as below:

OCSE:ALK B' s Beneish M-Score Range Over the Past 10 Years
Min: -2.84   Med: -2.43   Max: -1.99
Current: -2.71

During the past 13 years, the highest Beneish M-Score of Alk-Abello AS was -1.99. The lowest was -2.84. And the median was -2.43.


Alk-Abello AS Beneish M-Score Historical Data

The historical data trend for Alk-Abello AS's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alk-Abello AS Beneish M-Score Chart

Alk-Abello AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.34 -2.69 -2.62 -2.29 -2.59

Alk-Abello AS Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.35 -2.37 -2.59 -2.61 -2.71

Competitive Comparison of Alk-Abello AS's Beneish M-Score

For the Biotechnology subindustry, Alk-Abello AS's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alk-Abello AS's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alk-Abello AS's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Alk-Abello AS's Beneish M-Score falls into.



Alk-Abello AS Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Alk-Abello AS for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8633+0.528 * 0.9828+0.404 * 0.9398+0.892 * 1.1068+0.115 * 1.0214
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9512+4.679 * -0.050532-0.327 * 0.8227
=-2.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun24) TTM:Last Year (Jun23) TTM:
Total Receivables was kr880 Mil.
Revenue was 1374 + 1351 + 1345 + 1110 = kr5,180 Mil.
Gross Profit was 867 + 889 + 844 + 685 = kr3,285 Mil.
Total Current Assets was kr3,078 Mil.
Total Assets was kr7,045 Mil.
Property, Plant and Equipment(Net PPE) was kr2,273 Mil.
Depreciation, Depletion and Amortization(DDA) was kr257 Mil.
Selling, General, & Admin. Expense(SGA) was kr1,814 Mil.
Total Current Liabilities was kr1,154 Mil.
Long-Term Debt & Capital Lease Obligation was kr442 Mil.
Net Income was 201 + 232 + 140 + 117 = kr690 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = kr0 Mil.
Cash Flow from Operations was 259 + 283 + 326 + 178 = kr1,046 Mil.
Total Receivables was kr921 Mil.
Revenue was 1135 + 1234 + 1249 + 1062 = kr4,680 Mil.
Gross Profit was 707 + 799 + 771 + 640 = kr2,917 Mil.
Total Current Assets was kr2,706 Mil.
Total Assets was kr6,457 Mil.
Property, Plant and Equipment(Net PPE) was kr2,099 Mil.
Depreciation, Depletion and Amortization(DDA) was kr243 Mil.
Selling, General, & Admin. Expense(SGA) was kr1,723 Mil.
Total Current Liabilities was kr1,357 Mil.
Long-Term Debt & Capital Lease Obligation was kr421 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(880 / 5180) / (921 / 4680)
=0.169884 / 0.196795
=0.8633

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(2917 / 4680) / (3285 / 5180)
=0.623291 / 0.63417
=0.9828

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (3078 + 2273) / 7045) / (1 - (2706 + 2099) / 6457)
=0.240454 / 0.255846
=0.9398

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=5180 / 4680
=1.1068

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(243 / (243 + 2099)) / (257 / (257 + 2273))
=0.103757 / 0.101581
=1.0214

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1814 / 5180) / (1723 / 4680)
=0.350193 / 0.368162
=0.9512

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((442 + 1154) / 7045) / ((421 + 1357) / 6457)
=0.226544 / 0.27536
=0.8227

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(690 - 0 - 1046) / 7045
=-0.050532

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Alk-Abello AS has a M-score of -2.71 suggests that the company is unlikely to be a manipulator.


Alk-Abello AS Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Alk-Abello AS's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Alk-Abello AS Business Description

Traded in Other Exchanges
Address
Boge Alle 6-8, Horsholm, DNK, DK-2970
Alk-Abello A/S is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication.

Alk-Abello AS Headlines

No Headlines